StockData
Regencell Bioscience Holdings Ltd logo

Regencell Bioscience Holdings Ltd (RGC) stock

RGCNasdaqMedicinal Chemicals & Botanical Products
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30
$4.55−0.17 (-3.60%)

Close on Nov 17, 2026Market cap $2.26BP/E –Yield –

Regencell Bioscience EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2026 it was -$2.37. The highest annual figure on record is -$0.00 in fiscal 2020.

Annual eps

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$2.37–
FY2025Jun 30, 2025-$0.72–
FY2024Jun 30, 2024-$0.87–
FY2023Jun 30, 2023-$1.19–
FY2022Jun 30, 2022-$0.02–
FY2021Jun 30, 2021-$0.00–
FY2020Jun 30, 2020-$0.00–

More Regencell Bioscience figures

See a number that looks wrong?